05.10.2017 • NewsElaine BurridgeErgomedorphan drug

Ergomed Buys Dutch-based PSR Group

(c) totojang1977/Shutterstock
(c) totojang1977/Shutterstock

UK pharmaceutical company Ergomed has acquired PSR Group, a Dutch contract research organization (CRO) that specializes in orphan drug development and is regarded as a leading expert in rare diseases, for a total price of €5.7 million.

Under the terms of the transaction, Ergomed has made an initial payment of €3.2 million with a further sum of up to €2.5 million contingent upon achieving EBITDA targets in 2017, 2018 and 2019.

Ergomed said it would continue to grow the business under the PSR brand and remain focused on the two divisions - PSR Orphan Experts, which supports biotech and pharma companies with their regulatory and clinical development of orphan drugs, and PSR Pharma Resource, a niche staffing provider focused on orphan drug specialists.

Ergomed’s CEO, Dan Weng, said the acquisition fits with its strategy of becoming a leader in orphan drug development. PSR’s CEO, Roger Legtenberg added that it welcomed the opportunity to expand its portfolio and geographical coverage by leveraging Ergomed’s international reach and complementary services.

According to Ergomed, there is a total of 30 million people worldwide suffering from rare diseases. Consequently, the orphan drug market to target these diseases continues to grow, requiring highly specialized providers because of the regulatory, logistical and operational complexities of conducting clinical trials.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.